* Nephros Inc NEPH.OQ NEPH.O is expected to show a rise
in
quarterly revenue when it reports results on August 9.
* The South Orange New Jersey-based company is expected to
report
a 7.7% increase in revenue to $3.107 million from $2.88 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Nephros Inc is for
a loss
of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Nephros Inc
is
$3, above its last closing price of $1.39.
This summary was machine generated August 8 at 02:05 GMT. All
figures in US dollars unless otherwise stated